BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dakhoul L, Gawrieh S, Jones KR, Ghabril M, McShane C, Orman E, Vilar-Gomez E, Chalasani N, Nephew L. Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden. Hepatol Commun 2019;3:52-62. [PMID: 30619994 DOI: 10.1002/hep4.1277] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Liu H, Kaltenmeier C, Jonassaint N, Behari J, Duarte-rojo A, Malik S, Hughes DL, Ganesh S, Reddy D, Powers C, Lizeth C, Thompson A, Al Harakeh H, Hill R, Xingyu Z, Diego E, Di Martini A, Bataller R, Molinari M. The closing survival gap after liver transplantation for hepatocellular carcinoma in the United States. HPB 2022. [DOI: 10.1016/j.hpb.2022.07.008] [Reference Citation Analysis]
2 Wadhwani SI, Lai JC, Gottlieb LM. Medical Need, Financial Resources, and Transplant Accessibility. JAMA 2022. [PMID: 35357415 DOI: 10.1001/jama.2022.5283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Park C, Jones M, Kaplan S, Koller FL, Wilder JM, Boulware LE, Mcelroy LM. A scoping review of inequities in access to organ transplant in the United States. Int J Equity Health 2022;21. [DOI: 10.1186/s12939-021-01616-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
4 Goyes D, Nsubuga JP, Medina-Morales E, Barba R, Patwardhan V, Saberi B, Fricker Z, Bonder A. Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception Points. J Clin Med 2021;10:5826. [PMID: 34945122 DOI: 10.3390/jcm10245826] [Reference Citation Analysis]
5 Kronenfeld JP, Goel N. An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1209-19. [PMID: 34611524 DOI: 10.2147/JHC.S284430] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Malespin M, May EJ, Nephew LD, Paul S, McCary A, Kilaru S, Mukhtar NA, Hassan MA, Brady CW. AASLD Deepens Commitment to Diversity, Equity, and Inclusion. Hepatology 2021;74:2216-25. [PMID: 34028073 DOI: 10.1002/hep.31918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Winters AC, Shaltiel T, Sarpel U, Branch AD. Liver Cancer Has a Distinctive Profile in Black Patients: Current Screening Guidelines May Be Inadequate. Hepatol Commun 2021. [PMID: 34558225 DOI: 10.1002/hep4.1771] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Rosenblatt R, Wahid N, Halazun KJ, Kaplan A, Jesudian A, Lucero C, Lee J, Dove L, Fox A, Verna E, Samstein B, Fortune BE, Brown RS Jr. Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States. Hepatology 2021;74:1523-32. [PMID: 33779992 DOI: 10.1002/hep.31837] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
9 Mazumder NR, Simpson D, Atiemo K, Jackson K, Zhao L, Daud A, Kho A, Gabra LG, Caicedo JC, Levitsky J, Ladner DP. Black Patients With Cirrhosis Have Higher Mortality and Lower Transplant Rates: Results From a Metropolitan Cohort Study. Hepatology 2021;74:926-36. [PMID: 34128254 DOI: 10.1002/hep.31742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Connor KL, O'Sullivan ED, Marson LP, Wigmore SJ, Harrison EM. The Future Role of Machine Learning in Clinical Transplantation. Transplantation 2021;105:723-35. [PMID: 32826798 DOI: 10.1097/TP.0000000000003424] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
11 Wong RJ, Ahmed A; Hepatocellular Carcinoma Research Committee of the Chronic Liver Disease Foundation. Understanding Gaps in the Hepatocellular Carcinoma Cascade of Care: Opportunities to Improve Hepatocellular Carcinoma Outcomes.J Clin Gastroenterol. 2020;54:850-856. [PMID: 33030855 DOI: 10.1097/MCG.0000000000001422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Nephew LD, Serper M. Racial, Gender, and Socioeconomic Disparities in Liver Transplantation. Liver Transpl 2021;27:900-12. [PMID: 33492795 DOI: 10.1002/lt.25996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
13 Poulson MR, Blanco BA, Geary AD, Kenzik KM, McAneny DB, Tseng JF, Sachs TE. The role of racial segregation in treatment and outcomes among patients with hepatocellular carcinoma. HPB (Oxford) 2021;23:854-60. [PMID: 33536151 DOI: 10.1016/j.hpb.2020.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Rich NE, Carr C, Yopp AC, Marrero JA, Singal AG. Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31725-0. [PMID: 33387668 DOI: 10.1016/j.cgh.2020.12.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
15 Ajayi F, Jan J, Singal AG, Rich NE. Racial and Sex Disparities in Hepatocellular Carcinoma in the USA. Curr Hepatol Rep 2020;19:462-9. [PMID: 33828937 DOI: 10.1007/s11901-020-00554-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
16 Thylur RP, Roy SK, Shrivastava A, LaVeist TA, Shankar S, Srivastava RK. Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma. JGH Open 2020;4:351-9. [PMID: 32514436 DOI: 10.1002/jgh3.12336] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
17 Aby ES, Lake JR. Basic principles of liver allocation and development over the years. Curr Opin Organ Transplant 2020;25:99-103. [PMID: 32073495 DOI: 10.1097/MOT.0000000000000732] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Gutin L, Yao F, Dodge JL, Grab J, Mehta N. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance. JAMA Netw Open 2019;2:e1910326. [PMID: 31469395 DOI: 10.1001/jamanetworkopen.2019.10326] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]